AIMEDBIO

IR

Disclosure

69 posts
NO. Title Date Author
69 [Corrected description]Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인) 2026-09-22 에임드바이오
68 Report on status of specific securities, etc. owned by executives and major shareholders 2026-09-18 안선희
67 [Corrected description]Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인) 2026-09-02 에임드바이오
66 [Corrected description]Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인) 2026-08-21 에임드바이오
65 [Corrected description]Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인) 2026-08-18 에임드바이오
64 Semi-annual Report (2026.06) 2026-08-12 에임드바이오
63 [Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청) 2026-08-10 에임드바이오
62 [Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청) 2026-07-22 에임드바이오
61 Report on the Appointment, Dismissal or Early Retirement of Independent Directors 2026-07-16 에임드바이오
60 Outcomes of Extraordinary General Meeting of Shareholders 2026-07-16 에임드바이오
1 2 3 4 5